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Polysaccharides comprise an extremely important class of biopoly-
mers that play critical roles in a wide range of biological processes,
but the synthesis of these compounds is challenging because of
their complex structures. We have developed a chemoenzymatic
method for regioselective deprotection of monosaccharide sub-
strates using engineered Bacillus megaterium cytochrome P450
(P450BM3) demethylases that provides a highly efficient means
to access valuable intermediates, which can be converted to a
wide range of substituted monosaccharides and polysaccharides.
Demethylases displaying high levels of regioselectivity toward a
number of protected monosaccharides were identified using a
combination of protein and substrate engineering, suggesting that
this approach ultimately could be used in the synthesis of a wide
range of substituted mono- and polysaccharides for studies in
chemistry, biology, and medicine.
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Complex carbohydrates comprise an extremely importantclass of biopolymers that play critical roles in a number of
biological processes, including inflammation, cancer metastasis,
and bacterial and viral infection (1). Unlike nucleic acids and
proteins, oligosaccharides can be highly branched, and their
biosynthesis proceeds in a non–template-directed fashion to
produce complex mixtures of closely related structures that are
difficult, if not impossible, to separate (2). Because subtle
changes in the structures of these compounds can alter their
properties dramatically (3), detailed studies of oligosaccharide-
mediated events require the use of homogeneous synthetic
material (4). Oligosaccharide synthesis traditionally has been
accomplished through the installation and removal of various
orthogonally reactive protecting groups to differentiate each
position of a monosaccharide substrate, and a similar procedure
is used to synthesize glycosides and substituted monosaccharides
in which 1 hydroxyl group is used as a handle for the introduction
of small molecules or other functional groups (5). Despite
numerous advances in the synthesis of these materials during the
past decade, their preparation remains an arduous task (6).
Researchers have sought to simplify the preparation of suit-
ably protectedmonosaccharides with 1-pot synthetic procedures,
but these approaches require considerable synthetic expertise
and are limited in terms of substrate scope (7). Elimination of
protecting groups altogether also has been demonstrated using
enzymes to affect the glycosylation of various substrates (8). The
utility of this approach could be expanded greatly by identifying
or engineering additional enzymes (9), but the preparation of
substituted monosaccharides lies beyond its scope. Chemoenzy-
matic regioselective deprotection of a globally protected
monosaccharide is a potentially practical alternative to these
approaches. This approach has been demonstrated using lipases
to deprotect peracylated monosaccharides, but the range of
products reported has been limited thus far to those accessible
with known enzymes, and no attempt has been made to improve
or alter the biocatalyst activity or regioselectivity (10). Although
careful control of reaction conditions permits regioselective acyl
migration to produce other products (11), non-selective migra-
tion remains problematic, and the generality of the lipase
method seems to be limited.
The generality and utility of a chemoenzymatic method for the
synthesis of monosaccharide derivatives would be expanded
greatly if each site of a given substrate could be deprotected
using a unique catalyst. This approach would require not only a
protecting group resistant to migration under the deprotection
conditions but also a catalyst capable of removing this group with
high levels of chemo- and regioselectivity. We hypothesized that
cytochrome P450-catalyzed heteroatom demethylation might
provide a solution to both these problems. Although chemical
removal of methyl groups requires harsh and unselective con-
ditions, this enzyme-catalyzed reaction proceeds via insertion of
oxygen into a methyl C-H bond to generate a hemiacetal
intermediate that spontaneously decomposes to release form-
aldehyde and an alcohol under ambient conditions (Fig. 1A)
(12). One of our groups (F.H.A.) has used variants of Bacillus
megaterium cytochrome P450BM3 (BM3) to hydroxylate a wide
range of non-natural substrates with high levels of regioselec-
tivity (13). If this enzyme could be engineered to accept perm-
ethylated monosaccharides, the challenging task of regioselec-
tively demethylating these substrates could be possible. Because
BM3 is amenable to protein engineering, the activity, regios-
electivity, and substrate scope of these reactions could be
optimized using directed evolution (14) to generate BM3 dem-
ethylases for the production of any desired monosaccharide
derivative.
Results
We therefore screened libraries of BM3 variants on hand in our
laboratory to determine the scope of their reactivity toward a
number of common pentamethyl hexoses (Fig. 1C). A compi-
lation library comprised of 96 BM3 variants previously engi-
neered for a variety of applications was used to survey functional
enzymes rapidly (15). Because many of these variants were
related along an evolutionary lineage by mutation of 1–3 resi-
dues, we also used a targeted library of 1,024 BM3 variants
having up to 10 mutations in the active site of the parent variant,
9–10A. Demethylase activity first was determined using a high-
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throughput (HT) colorimetric assay for formaldehyde released
during the reactions (Fig. 1A; see supporting information (SI)
Appendix). The most active enzymes then were re-expressed,
purified, and used to catalyze the same reaction under controlled
conditions to ensure the accuracy and precision of catalyst
loadings. Finally, the reaction mixtures were analyzed by gas
chromatography (GC) to establish the regioselectivity of de-
methylation. Promising variants were optimized by incorpora-
tion of random mutations and screening to provide total turn-
over numbers (TTN, ca. 1,000) and regioselectivities ( 80%)
sufficient for practical gram-scale preparation of regioselectively
deprotected monosaccharides. This approach also was used to
identify variants capable of removing the methoxymethyl
(MOM) group from MOM-protected monosaccharides to en-
able additional synthetic applications (Fig. 1B).
Initially, 4 substrates, 1,2,3,4,6-pentamethyl--glucopyrano-
side (1), 1,2,3,4,6-pentamethyl--galactopyranoside (2),
1,2,3,4,6-pentamethyl--mannopyranoside (3), and 1-benzyl-
2,3,4,6-tetramethyl--glucopyranoside (4) (Fig. 2A) were exam-
ined. The last of these compounds, 4, was included to determine
if a substrate-engineering approach (16) could lead to alter-
native regioselectivities, and authentic samples of each of the
possible mono-demethylation products for 1–4 were synthesized
to serve as GC standards for product identification. We first
screened the compilation library for activity on these substrates
(Fig. 2B). Pleasingly, we found that a number of enzymes in this
small library were active on substrates 1, 3, and 4 in the HT assay,
and GC analysis of these same reactions conducted with purified
enzymes under optimized conditions (17) revealed that, except
for C-1, nearly every position of the monosaccharide substrates
investigated was accessible (Fig. 2 C–F). This broad range of
regioselectivities contrasts with the narrow scope of existing
chemoenzymatic methods and suggested that BM3-catalyzed
demethylation could provide a general approach to monosac-
charide elaboration if the yields and regioselectivities observed
for these enzymes could be improved using directed evolution.
Furthermore, the significant differences in both activity and
regioselectivity between the methyl- and benzyl-protected glu-
cose substrates 3 and 4 indicated that varying the anomeric
substituent could be used to identify suitable enzyme/substrate
combinations without the need for protein engineering. Indeed,
variant 9–10A F87I catalyzed the demethylation of both 3 and
4 with suitably high yield ( 1,000 TTN) and regioselectivity (
80%) to warrant investigation of these reactions on a preparative
scale, as discussed later.
Although these results were very promising, we were con-
cerned about the lack of reactivity observed with galactose
substrate 2, especially given the frequency with which this
monosaccharide is found in natural systems (1). To address this
issue, we examined the activities of the compilation library
enzymes on 4 additional tetramethyl galactose derivatives with a
variety of anomeric substituents in the  configuration, including
methyl (Me, 5), benzyl (Bn, 6), benzoyl (Bz, 7), and acetyl (Ac,
8). Once again, 9–10A F87I displayed high demethylation ac-
tivity, this time on the 1--benzyl galactose substrate 6, and
nearly quantitative conversion and high selectivity for the 4-po-
sition was confirmed by NMR spectroscopy. This result further
established the utility of substrate engineering to achieve highly
selective demethylation reactions and confirmed that derivatives
of 3 of the most common hexoses were compatible with our
enzymatic demethylation method.
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Fig. 1. (A) P450-catalyzed removal ofmethyl (Me) and (B)methoxymethyl (MOM)groups. (C)Methodused to screenandoptimize activity of BM3demethylases.
Libraries of BM3 variants were screened for activity on Me- or MOM-protected substrates. The activity of BM3 variants in cell lysate was assayed by colorimetric
detection of formaldehyde (CH2O) released during the deprotection, and regioselectivity was determined by GC analysis of the reaction mixtures. Promising
enzymes were optimized by directed evolution to provide enzymes suitable for preparative scale. Mono-demethylated products were converted to a variety of
value-added products.
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To broaden the generality of the method further, we explored
the activities of the active-site library enzymes on - and
-pentamethyl galactose substrates 2 and 5 because galactose
derivatives had proven most resistant to demethylation by the
small set of enzymes surveyed thus far (Fig. 3A). A number of
hits were obtained in the HT assay, and 8 of the most active
variants were purified and re-screened against substrates 2, 5, 6,
7, and 8. Colorimetric analysis of formaldehyde produced in
these reactions confirmed the activity observed on 2 and 5 but
also indicated that 7 is a compatible substrate (see SI Appendix).
Six variants catalyzed the demethylation of these substrates with
moderate efficiency (ca. 30% conversion based on formaldehyde
concentration), indicating that active-site engineering could
extend further the scope of the reaction.
GC analysis of the crude reaction mixtures obtained with 2
revealed that variant 2C6dr provided the highest conversion of
substrate, producing a 1:1 mixture of O-2 (39%) and O-3 (41%)
demethylation (compounds 9 and 10). Although the activity of
2C6dr on 5 and 7 was slightly lower under these reaction
conditions, we observed nearly exclusive O-3 demethylation with
these compounds to give 11 (50%) and 12 (57%), as confirmed
by NMR spectroscopy and x-ray analysis, respectively. These
results indicated that the remaining 2 secondary hydroxyl posi-
tions of galactose could be accessed, but both the conversion and
regioselectivity of these transformations required improvement
for practical synthetic applications.
A combination of random and site-directedmutagenesis of the
gene for 2C6dr led to the identification of variant E12r12, which
had improved efficiency on substrates 2 (50% increase in
regioselectivity) and 5 (100% conversion) because of active-site
mutation A180V (see SI Appendix). Variant 5E5 was obtained
from an additional round of random mutagenesis of the gene for
E12r12 and recombination of improved variants, and this en-
zyme provided high regioselectivity in the conversion of 2 to 9
(96%, single isomer) because of active-site mutation V87G. A
similar engineering effort led to the generation of B1SYN, which
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had improved activity on 7 dramatically and enabled quantitative
demethylation of this substrate even at 0.05 mol% enzyme
loading. Fig. 3B shows the improvement in the conversion of 2
to a mixture of 9 and 10, of 5 to 11, and of 7 to 12 using the
evolved BM3 variants. In each case, the activity or regioselec-
tivity of 2C6dr was improved sufficiently by mutations identified
from 1 or 2 rounds of error-prone PCR and screening to enable
efficient demethylation of the 2- and 3-positions of suitable
-galactose derivatives. Given the range of activities and regi-
oselectivities observed for BM3 variants identified from screen-
ing both the compilation and active-site libraries (Fig. 2 C–F),
directed evolution should provide a rapid means for optimizing
demethylases well beyond the examples shown here.
Next, the synthetic utility of the engineered demethylases was
demonstrated by their application in preparative-scale reactions
(Fig. 4A). The high conversions and regioselectivities observed
previously in small-scale reactions translated well into the 100-mg
scale investigated, and the desired products, 9–15, were isolated in
high yield using 0.05–0.1 mol% enzyme loading. These mono-
demethylated compounds could be converted to a variety of
biologically relevant products using established chemical transfor-
mations. Fluorination frequently is used to modify the pharmaco-
kinetic properties of molecules for biological studies or for PET
imaging (18). The Arnold group previously reported the tandem
demethylation/fluorination of a variety of small molecules (15), and
this procedure proved applicable for the fluorination of 13 to
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provide 16. The latter compound could be demethylated in quan-
titative yield and per-acetylated to provide 17 in 55% yield over 2
steps. Deoxy sugars also are important components of a variety of
small-molecule therapeutics (19), and deoxygenation of 12 using
Barton conditions proceeded smoothly to provide 18 in good yield
(20). This product was demethylated in excellent yield (19) and was
acetylated (20) to facilitate handling and characterization.
To augment the utility of our method further, we explored the
regioselective deprotection of MOM-protected monosacchar-
ides in the context of a chemoenzymatic disaccharide synthesis
(Fig. 1B). The ability to remove the MOM group is highly
valuable for the synthesis of complex molecules, because the
conditions required for its removal are much milder than those
required for removal of methyl groups and therefore are com-
patible with sensitive functionality (21). A number of substrates
with differing sugar scaffolds, anomeric substituents, and ano-
meric configurations were synthesized, and the compilation
library was screened for activity on these substrates. High activity
was observed on a number of MOM-protected pentoses without
the need for any protein engineering, and GC analysis of reactions
catalyzed by the most active variants revealed that 9–10A F87V
catalyzed the removal of a single MOM group from -xylose
substrate 21. Importantly, the product, 22, could be isolated in
moderate yield on a preparative scale, and removal of the 3-MOM
group was confirmed by NMR spectroscopy (Fig. 5A). Compound
22 could be glycosylated with trichloroacetimidate donor 23 to give
disaccharide 24 in high yield (22). Global deprotection of 24 under
mild conditions provided disaccharide 25, a component of the
promising immune adjuvant, QS-21 (Fig. 5B) (23).
Discussion
Regioselective deprotection of monosaccharide substrates using
engineered P450BM3 demethylases provides a highly efficient
means to access valuable intermediates that can be converted to
a wide range of substituted monosaccharides and polysaccha-
rides. Demethylases with activity on a number of monosaccha-
rides and different positions on a given monosaccharide were
identified using a combination of protein and substrate engi-
neering, suggesting that this procedure ultimately could be used
to functionalize regioselectively any monosaccharide at any
desired position. The ability of these enzymes (i.e., 9–10A
F87Idr) to catalyze efficient demethylation of various substrates
with high regioselectivity should greatly simplify the expansion
of the method to additional substrates.
These results also highlight the efficiency with which BM3
variants can insert oxygen into the C-H bonds of methyl ethers
to catalyze heteroatom demethylation under conditions far more
mild than those associated with chemical methods. Furthermore,
the ability of the demethylases to situate substrates in a particular
orientation to favor hydroxylation of a particular methyl group
over 3 or 4 others located within only a few angstroms indicates
the exquisite control imparted by supramolecular interactions.
Unlike synthetic supramolecular catalysts (24), the activity and
selectivity of BM3 variants can be tuned readily to suit a
particular application. Such control enables efficient hydroxyla-
tion of C-H bonds lacking any significant stereoelectronic dif-
ferentiation and augments themeans by which synthetic chemists
can target otherwise indistinguishable C-H bonds (25).
All these factors result in a procedure that greatly simplifies
the synthesis of selectively deprotected monosaccharide deriv-
atives compared with conventional procedures that require
extensive synthetic manipulation. The extension of this technol-
ogy to additional synthetically useful protecting groups, such as
the MOM ether, renders the method compatible with sensitive
glycosidic linkages and greatly expands the scope of the reaction.
We anticipate that this chemoenzymatic approach could greatly
simplify the synthesis of a wide range of polysaccharides for
studies in chemistry, biology, and medicine.
Materials and Methods
Experimental Procedures and Characterization. Complete experimental proce-
dures and characterization can be found in the online SI Appendix.
BM3 Expression and Purification. For preparative bioconversions, P450 BM3
demethylases were used in purified form. Enzyme batches were prepared as
follows. We inoculated 2 L TBamp with an overnight culture (100 mL, LBamp) of
recombinant E. coli DH5 cells harboring a pCWori plasmid encoding for the
P450 variant under the control of Plac promoter. At anOD600 of 1.8 (ca. 3–4 h),
the incubation temperature was reduced to 25 °C (30 min), and the cultures
were induced by adding isopropyl-beta-D-thiogalactopyranoside to a final
concentration of 0.1 mM. The cultures were allowed to continue at this
temperature for another 24h.After the cellswereharvestedby centrifugation
(4 °C, 15 min, 3000  g), the cell pellet was resuspended in 25 mM Tris-HCl
buffer (pH 8.0), and cells were disrupted by sonication (4  1 min, 50% duty
cycle). Cell debris was removed by centrifugation for 20 min at 4 °C and
20,000 g; the resulting cell lysatewas loaded onto aQ resin, and the column
was washedwith 3 column volumes of 25mM Tris-HCl (pH 8.0), 150mMNaCl.
Bound proteinwas elutedwith 25mMTris-HCl (pH 8.0), 340mMNaCl andwas
concentratedusingMillipore Centricon tubes. After buffer exchangewith 100
mM KPi (pH 8.0), protein samples were frozen and stored at 80 °C. Protein
concentration was determined in duplicate from CO-difference spectra as
previously described. Yields typically ranged between 100 and 500 mg pro-
tein/L, depending on the variant.
Preparative-Scale Bioconversions. Potassium phosphate buffer (100mM, pH 8)
and a solution of the desired substrate in phosphate buffer or DMSO (1 equiv,
5 mMfinal concentration) was added to a 100 50mm crystallizing dish (i.e.,
ChemGlass #CG-8276–100). A solution of NADP (0.1 equiv, 0.5 mM final
concentration), glucose-6-phosphate (10 equiv, 50 mM final concentration),
and glucose-6-phosphate dehydrogenase (2 units/mL final reaction volume)
was added.A solutionof the appropriate BM3variant (0.001 equiv, 5mMfinal
concentration) was added, the dish was covered loosely with aluminum foil,
and the contentswere stirred using amagnetic stir bar. Themoderate stir rate
was used to allow efficient O2 transfer to the reactionmixture while avoiding
foaming. The reaction progress could be monitored by analyzing aliquots of
the reaction mixture as described for the medium-scale bioconversions. After
12 h, the pHof the reactionmixturewas adjusted to 3–4, and the solutionwas
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Fig. 5. (A) Regioselective removal of 3-MOM group from substrate 21. (B) Synthesis of QS21-A disaccharide 25. a, TMSOTf, 4ÅMS, 88%; b, NaOMe; c, 2 M HCl,
55% (2 steps)
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saturated with NaCl to precipitate most of the protein from solution. The
resulting suspension then was filtered through Celite (Aldrich), which was
rinsedwithmethylene chloride toprovide abiphasicmixture. Themixturewas
transferred to a separatory funnel and extracted with 4  75 mL CH2Cl2. The
combined organic extracts were dried with sodium sulfate, filtered, and
concentrated. The resulting residue was purified by SiO2 chromatography
eluting with ethyl acetate/hexanes.
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